Palvella Therapeutics earnings were -$26.6M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest PVLA earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$9.5M, up 15.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PVLA reported annual earnings of -$17.4M, with -197.3% growth.
Palvella Therapeutics Earnings Reports & History FAQ
What were Palvella Therapeutics's earnings last quarter?
On PVLA's earnings call on Invalid Date, Palvella Therapeutics (NASDAQ: PVLA) reported Q2 2025 earnings per share (EPS) of -$0.86, up 65.18% year over year. Total PVLA earnings for the quarter were -$9.47 million. In the same quarter last year, Palvella Therapeutics's earnings per share (EPS) was -$2.47.
Is Palvella Therapeutics profitable or losing money?
As of the last Palvella Therapeutics earnings report, Palvella Therapeutics is currently losing money. Palvella Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$26.61 million, a 225.57% decrease year over year.
What was PVLA's earnings growth in the past year?
As of Palvella Therapeutics's earnings date in Invalid Date, Palvella Therapeutics's earnings has grown year over year. PVLA earnings in the past year totalled -$26.61 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.